|
|
||||||||
1 Faculté de Pharmacie
and 3 Département de
Kinésiologie, The purpose of
this study was to verify the possible appearance in the blood of
bradykinin (BK) and
des-Arg9-bradykinin
(des-Arg9-BK) after eccentric
exercise in 13 male subjects. Eccentric exercise (5 × 10 leg
presses at 120% maximal voluntary concentric contraction) resulted in
muscle damage and inflammation, as suggested by the significant
increase in serum creatine kinase activity (from 204 ± 41 to 322 ± 63 U/l 12 h postexercise) and by severe lasting pain, which also
peaked at 12 h postexercise. Blood BK and
des-Arg9-BK concentrations were
measured by competitive enzyme immunoassays using highly specific
polyclonal rabbit IgG. Des-Arg9-BK
concentration was not modified (preexercise: 44 ± 14 pmol/l; pooled
postexercise: 47 ± 4 pmol/l). In contrast, BK concentration significantly increased immediately after the exercise session (68 ± 9 vs. 42 ± 3 pmol/l preexercise) and returned to basal values at 12, 24, and 48 h (pooled value: 40 ± 4 pmol/l). This observation suggests that the inflammatory process due to eccentric
exercise-induced muscle damage could be mediated in part by BK.
creatine kinase; delayed-onset muscle soreness; kinins; inflamation; des-Arg9-bradykinin
EXERCISE, particularly unaccustomed strenuous exercise,
eccentric contractions, and contractions performed at long muscle length can result in delayed-onset muscle soreness (DOMS) (for review
see, e.g., Refs. 1, 7, 14, 17, 21, 24, 33, and 37). Brendstrup
[see Armstrong (1)] was apparently the first author to
suggest that DOMS could be associated with an inflammatory process
triggered by exercise-induced muscle damage. Damage to the muscle after
various types of exercise has, indeed, been demonstrated from direct
morphological evidence (16, 17) as well as from changes in a number of
markers of tissue damage and repair. Serum creatine kinase (CK)
concentration and/or activity are the most common markers used (e.g.,
see Refs. 4-6, 8, 18-20, 25, 28, 29, 36, and 37). Evidence of
cell disruption and of increase in collagen and myosin turnover has
also been shown by using other serum or urinary markers, e.g.,
aspartate (5, 29) and alanine aminotransferases (5), alkaline
phosphatase (4, 5), lactate dehydrogenase (4, 5, 29), carbonic anhydrase (39), myoglobin (8, 19, 39), myosin heavy chain (25),
galactosylhydroxylysyl glucosyltransferase (39), hydroxylysine and
hydroxyproline (4), and pre-pro-collagens (39).
The hypothesis of an inflammatory process in the muscle as a
consequence of this damage is consistent with the major signs and
symptoms observed, such as muscle pain (i.e., DOMS), swelling, and the
loss of functions, such as reduction in flexibility and strength (7,
24, 37) but also reduction in insulin sensitivity (19), the ability to
store glycogen, and endurance (2). Data concerning specific
histological and biochemical markers of inflammation are also in line
with this hypothesis: changes in plasma white blood cell subpopulations
(5, 6, 39) and infiltration of white blood cells in the muscle (16, 18,
23); increase in plasma (5, 18) and tissue cytokine concentrations
(16); and activation of the complement pathway (6). The recent report (18) of an activation of xanthine oxidase in the microvascular endothelial cells of muscles and in infiltrating leukocytes after exercise is also consistent with the hypothesis of an inflammatory process. Finally, this hypothesis is also consistent with the observation that anti-inflammatory drugs could reduce DOMS
and some of its associated signs (see, e.g., Ref. 22).
Several models have been proposed to explain how exercise could trigger
an inflammatory response in the muscle (1, 14, 24, 33, 37). A common
feature of these models is the involvment of various mediators of
inflammation, including histamine, serotonin, nitric oxide, cytokines,
prostaglandins, oxygen free radicals, and kinins. However, except for
some cytokines (5, 16, 18), the involvement of these various putative
factors in the response to exercise-induced muscle damage and in DOMS
remains hypothetical.
The purpose of the present experiment was to verify the possible
appearance of bradykinin (BK) and of its active metabolite des-Arg9-bradykinin
(des-Arg9-BK) in the blood after
muscle damage, triggered by eccentric exercise and associated with
DOMS. BK and des-Arg9-BK are
powerful mediators of inflammation (13) and, as suggested by Armstrong
(1) and by MacIntyre et al. (24), could be involved in the processes
linking exercise-induced muscle damage to inflammation and DOMS.
Subjects. The experiment was
conducted on 13 active and healthy male subjects who gave their
informed written consent to participate in the study, which was
approved by the Institutional Board on the Use of Human Subjects in
Research. Their age, height, and weight were 22.7 ± 0.6 (SE) yr,
177.2 ± 1.7 cm, and 75.3 ± 1.8 kg, respectively. None of the
subjects was taking part in any regular training program at the time of experiment.
Exercise. The subjects performed a
weight-training exercise session on a supine leg-press training
apparatus (Trotter, Madway, MA). The exercise consisted of five sets of
10 eccentric contractions of the extensor muscles of the lower limbs at
120% of the maximal strength measured in concentric contraction, or
1.76 ± 0.07 kN. For this purpose, the maximal strength, which could
be developed during a single concentric contraction, was measured in a
preliminary test session 1 wk before the experiment (1.47 ± 0.06 kN). The day of the experiment, two aides lifted the weight in the
upper position on the leg-press apparatus while the subject extended his lower limbs against no resistance. The subject then lowered the
charge as slowly as possible. Each eccentric contraction took ~3 s. A
5-s rest period was allowed between the contractions while the weight
was lifted again by the aides to starting position. A
5-min rest period was allowed between two consecutive sets of contractions. The entire exercise session, which included 10 unaided concentric-eccentric contractions at 50% of the maximal concentric strength as a warm-up, lasted ~45 min.
Measurements. The day of the
experiment, observations and blood sampling from an antecubital vein
(10 ml) were performed at rest before the beginning of the exercise
session (between 6:00 and 7:00 PM) and immediately after the exercise
period. Observations and blood samplings were also taken 12, 24, and 48 h after the end of the exercise session.
For the measurement of CK activity, 5-ml blood samples were centrifuged
(2,000 g, 10 min, 4°C), and the
serum was stored at For the measurement of BK and
des-Arg9-BK concentrations, 5-ml
blood samples were immediately collected in polypropylene tubes containing 15 ml of ice-cold ethanol. The tubes were shaken vigorously and left to stand in crushed ice before centrifugation (2,000 g, 15 min, 4°C). The clear
supernatant was collected and evaporated to dryness (Speed Vac
Concentrator, Savant, Farmingdale, NY). The residues obtained were
resuspended in 2 ml of trifluoroacetic acid (0.1% vol/vol) and
purified on a 1-ml Waters Sep-Pak Vac C8-silica cartridge (Millipore,
Milford, MA). The eluates were then evaporated to dryness, and the
residues were stored at Muscle soreness was assessed for the right quadriceps muscle on a
four-level scale: 0 = no pain; 1 = pain when palpated; 2 = pain when
contracted; and 3 = painful at rest.
Statistics. Values are means ± SE.
Comparisons were made by using analysis of variance for repeated
measures and a Tukey's post hoc test. Statistical significance was set
at P < 0.05.
Serum CK activity and BK and
des-Arg9-BK concentrations in the
blood before and after the exercise session are shown in Figs. 1 and 2,
respectively. Immediately after the exercise session, serum CK activity
was slighltly (19 ± 3%) but significantly increased above basal
value. The peak value was observed 12 h after the exercise session (64 ± 15%, with wide interindividual variations: range
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
20°C until analysis. Serum CK activity
was assayed by using an automatic enzymatic method (Hitachi 717) with
commercially available reagents (Boehringer-Mannheim).
80°C until analysis. Immunoreactive
BK was quantified in the residue resuspended in 400 µl of a
Tris · HCl buffer (50 mM, pH 7.4), containing NaCl
(100 mM) and Tween-20 (0.5 ml/l), by a competitive enzyme immunoassay
(10). This assay uses highly specific polyclonal rabbit IgGs raised
against the carboxy terminal end of BK, digoxigenin-labeled BK as
tracer, and alkaline phosphatase-labeled Fab fragments
anti-digoxigenin, with the substrat
p-nitrophenyl phosphate to detect and
quantify the immune complexes. Typical calibration curves for BK were
characterized by a half-maximal saturation value of 0.78 pmol/ml (10).
Immunoreactive des-Arg9-BK was
quantified by using a similar analytical approach to that described by
Raymond et al. (34).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
20 to
+170%). Serum CK activity decreased thereafter and was back to basal
values 48 h after the exercise bout.

View larger version (16K):
[in a new window]
Fig. 1.
Serum creatine kinase activity (A) and muscle soreness
(B) on a 4-level scale immediately before (Pre) and after
(Post) exercise session and 12, 24, and 48 h after exercise session.
Values are means ± SE; n = 13 men. * Significantly different from preexercise value,
P < 0.05.

View larger version (17K):
[in a new window]
Fig. 2.
Bradykinin (BK; A) and
des-Arg9-bradykinin
(des-Arg9-BK; B)
concentrations in blood immediately before (Pre) and after (Post)
exercise session and 12, 24, and 48 h after exercise session. Values
are means ± SE; n = 13 men for BK;
n for
des-Arg9-BK is indicated in
parentheses. * Significantly different from preexercise value,
P < 0.05.
Blood BK concentration averaged 42 ± 3 pmol/l before the exercise
session. A significant 68 ± 27% increase was observed immediately after the exercise session, also with wide interindividual variations (range:
47 to +330%). Blood BK concentration was back to basal values 12 h after the exercise session and remained unchanged thereafter.
The presence of des-Arg9-BK was detectable in the blood in only 38 of the 65 samples analyzed (58%). No significant change from preexercise value (44 ± 15 pmol/l) was observed immediately after exercise or on the following days (pooled average postexercise value: 40 ± 5 pmol/l; n = 42 samples).
Severe pain developed in the quadriceps muscle immediately after the exercise session (Fig. 1) and further increased to reach a peak 12 h after the exercise session. Some of the subjects were still experiencing some pain 7 days after the exercise session, when a follow-up informal survey was made.
| |
DISCUSSION |
|---|
|
|
|---|
Severe and lasting pain in the extensor muscles of the lower limb was induced by the high-intensity eccentric weight-training exercise performed. The pain, which was present immediately after the exercise session but increased the following days, with a peak at 12 h after exercise, was typical of DOMS (4, 7, 8, 18, 24, 25, 28, 29, 36). Associated with muscle soreness was an increase in serum CK activity, which was apparent at the end of the exercise session but was more marked 13 and 24 h later. Increase in serum CK activity or concentration is a very consistent finding associated with DOMS (e.g., see Refs. 4-6, 8, 18-20, 25, 28, 29, 36, and 37) and is generally considered a marker of exercise-induced muscle damage (20).
The current hypothesis for explaining DOMS, muscle swelling, and loss of muscle functions after exercise suggests that exercise-induced muscle damage triggers an inflammatory process (1, 24, 33, 37). Although this hypothesis is consistent with most of experimental evidence (see the introductory section), direct evidence of the appearance of the classic mediators of inflammation remains limited, except for some cytokines (5, 16, 18). Endo et al. (15) have recently reported in mice that exercise increases the activity of histidine decarboxylase in the muscle, suggesting that histamine could be involved in the development of fatigue and DOMS. In contrast, involvement of prostaglandins (8) and oxygen reactive species (8, 18, 36) has proven difficult to ascertain.
The present study was performed to verify the possible appearance of BK and des-Arg9-BK in the blood in response to eccentric exercise resulting in muscle damage and DOMS. BK is formed from kininogen precursors upon the action of tissue and plasma kininogenases, which are activated by various stimuli, including tissue damage and injury, anoxia, and acidosis, whereas its active metabolite des-Arg9-BK is produced upon the action of kininase I (see Ref. 13 for a review). BK and des-Arg9-BK, or kinins, acting on B2 and B1 kinin receptors (27), are powerful proinflammatory factors. They produce local edema and activate and sensitize sensory and sympathetic nerve endings, with the release of other mediators of inflammation (e.g., prostanoids, substance P, neurokinin A, and calcitonin gene-related peptide), which mediate some of the local action of kinins and amplify their proinflammatory, nociceptive, and algesic effects. Kinins also attract leukocytes, activate the phagocytic function, and increase production and release of inflammatory mediators from neutrophils and macrophages.
In experimental models of inflammation in rat, BK plays a major role in the development of the acute inflammatory process (9), whereas both BK and des-Arg9-BK are involved in the development of sustained inflammation (3). BK could also be generated in the exercising muscle (12, 31, 35, 38). We thus hypothesized that BK could play a role in the acute development of muscle inflammation after exercise-induced muscle damage, whereas both BK and des-Arg9-BK could play a role in the sustained inflammation observed the following days. We also hypothesized that the involvement of these peptides in the inflammatory process in the tissue could be reflected by changes in their concentration in the blood.
BK concentrations in blood sampled before the exercise session (42 ± 3 pmol/l) and at 12, 24, and 48 h after the exercise session
(pooled average value 47 ± 4 pmol/l;
n = 42 samples) were slightly higher
but consistent with basal values observed by Pellacani et al. (32), who
used various methods of extraction and assays (17-36 pmo/l), and
in our own laboratory (29 ± 9 pmol/l) (26). In hemodialyzed
patients, despite the inflammatory process triggered by the dialysis
membrane, BK concentration in peripheral blood was not significantly
modified 20 min after the start of dialysis (26). In contrast,
Nussberger et al. (30) observed moderate (×2) -to-large increases
(×35) in blood BK concentration in patients with angioedema. In
the present experiment, immediately after the exercise session, BK
concentration in peripheral blood also increased above basal values
observed before exercise or 12, 24, and 48 h after the end of exercise.
The average response remained modest (64 ± 15%), and wide
interindividual variations were observed (range of change: from
9 to 98 pmol/l), but the increase was statistically significant
and was observed in 10 of the 13 subjects. This transient increase in
blood BK concentration immediately after exercise is a further support
to the hypothesis that eccentric exercise triggers an acute
inflammatory process that could be mediated, at least in part, by the
generation of BK in the exercising muscles with a spillover in the blood.
In contrast to the transient change in blood BK concentration, no significant change from basal preexercise value was observed for des-Arg9-BK immediately after exercise. This observation is consistent with the results from our laboratory, suggesting that the conversion of BK into des-Arg9-BK in the blood is only a minor pathway in humans, contributing only ~3.5% to BK degradation (11).
Blood BK concentration had returned to the basal value 12 h after the exercise session and remained unchanged thereafter, and no significant changes in des-Arg9-BK concentration were observed. This could indicate that none of the kinins are involved in the sustained inflammatory process after eccentric exercise. An alternate and more likely hypothesis is that kinins are involved in this process but that their generation in the inflammed muscle does not translate into changes in their concentration in peripheral blood.
The present study does not allow us to ascertain the mechanisms by which the eccentric weight-training exercise performed acutely increased BK concentration in the blood, the source of BK found in the blood in higher amounts after than before exercise, and the possible role of BK in the development and maintenance of muscle inflammation and DOMS. Isometric muscle contraction for 30 s, which is unlikely to result in muscle damage, is associated with the generation of BK in the tissue (38). This suggests that the appearance of BK in the muscle could be a normal event, but the mechanism by which muscle contraction locally triggers the kininogenase-kinin system remains unknown. This mechanism could be responsible for an increase in tissue BK concentration with a spillover in the blood in response to the high-intensity eccentric exercise performed in the present study. Additionally, tissue kininogenases could have been activated by substances released from disrupted cells or extracellular structures as a consequence of exercise-induced muscle damage. The resulting buildup of BK in the tissue could explain that it escaped inactivation and leaked into the blood. Under this hypothesis, the increase in BK concentration in the tissue could play a role in the development of an inflammatory response, including pain. Alternately, BK could have been generated in organs and tissues other than the exercising muscles, from which it could have been released. Finally, it cannot be excluded that BK was also generated in the blood as a consequence of activation of plasma kininogenases by unidentified substances released from the muscle and/or other tissues.
| |
ACKNOWLEDGEMENTS |
|---|
We gratefully aknowledge the technical assistance of Nathalie Rhéaume and Habib Oueslati for supervising the weight-training exercise sessions.
| |
FOOTNOTES |
|---|
This study was supported by grants from the Natural Science and Engineering Research Council of Canada and from the Fonds pour la Formation de Chercheurs et l'Aide à la Recherche du Québec. C. Blais, Jr., is a recipient of a PhD fellowship from the Fonds de Recherche en Santé du Québec.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: F. Péronnet, Département de Kinésiologie, Université de Montréal, CP 6128 Centre Ville, Montréal, PQ, Canada H3C 3J7 (E-mail: francois.peronnet{at}umontreal.ca).
Received 15 December 1998; accepted in final form 6 May 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Armstrong, R. B.
Mechanisms of exercise-induced delayed onset muscular soreness: a brief review.
Med. Sci. Sports Exerc.
16:
529-538,
1984[Medline].
2.
Asp, S.,
J. R. Daugaard,
S. Kristiansen,
B. Kiens,
and
E. A. Richter.
Exercise metabolism in human skeletal muscle exposed to prior eccentric exercise.
J. Physiol. (Lond.)
509:
305-313,
1998
3.
Blais, C., Jr.,
R. Couture,
G. Drapeau,
R. W. Colman,
and
A. Adam.
Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat.
Arthritis Rheum.
40:
1327-1333,
1997[Medline].
4.
Brown, S. J.,
R. B. Child,
S. H. Day,
and
A. E. Donnelly.
Indices of skeletal muscle damage and connective tissue breakdown following eccentric muscle contractions.
Eur. J. Appl. Physiol.
75:
369-374,
1997.
5.
Bruunsgaard, H.,
H. Galbo,
J. Halkjaer-Kristensen,
T. L. Johansen,
D. A. MacLean,
and
B. K. Pedersen.
Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage.
J. Physiol. (Lond.)
499:
833-841,
1997.
6.
Cannon, J. G.,
M. A. Fiatarone,
R. A. Fielding,
and
W. J. Evans.
Aging and stress-induced changes in complement activation and neutrophil mobilization.
J. Appl. Physiol.
76:
2616-2620,
1994
7.
Clarkson, P. M.,
K. Nosaka,
and
B. Braun.
Muscle function after exercise-induced muscle damage and rapid adaptation.
Med. Sci. Sports Exerc.
24:
512-520,
1992[Medline].
8.
Croisier, J. L.,
G. Camus,
G. Deby-Dupont,
F. Bertrand,
C. Lhermerout,
J. M. Crielaard,
A. Juchmes-Ferir,
C. Deby,
A. Albert,
and
M. Lamy.
Myocellular enzyme leakage, polymorphonuclear neutrophil activation and delayed onset muscle soreness induced by isokinetic eccentric exercise.
Arch. Physiol. Biochem.
104:
322-329,
1996[Medline].
9.
Décarie, A.,
A. Adam,
and
R. Couture.
Effects of captopril and icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan-induced edema.
Peptides
17:
1009-1015,
1996[Medline].
10.
Décarie, A.,
G. Drapeau,
J. Closset,
R. Couture,
and
A. Adam.
Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues.
Peptides
15:
511-508,
1994[Medline].
11.
Décarie, A.,
P. Raymond,
N. Gervais,
R. Couture,
and
A. Adam.
Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H1340-H1347,
1996
12.
Dietze, G. J.,
M. Wicklmayr,
K. Rett,
S. Jacob,
and
E. J. Henriksen.
Potential role of bradykinin in forearm muscle metabolism in humans.
Diabetes
45, Suppl. 1:
S110-S114,
1996.
13.
Dray, A.,
and
M. Perkins.
Bradykinin and inflammatory pain.
Trends Neurosci.
16:
99-104,
1993[Medline].
14.
Ebbeling, C. B.,
and
P. M. Clarkson.
Exercise-induced muscle damage and adaptation.
Sports Med.
7:
207-234,
1989[Medline].
15.
Endo, Y.,
T. Tabata,
H. Kuroda,
T. Tadano,
K. Matsushima,
and
M. Watanabe.
Induction of histidine decarboxylase in skeletal muscle in mice by electrical stimulation, prolonged walking and interleukin-1.
J. Physiol. (Lond.)
509:
587-598,
1998
16.
Fielding, R. A.,
T. J. Manfredi,
W. Ding,
M. A. Fiatarone,
W. J. Evans,
and
J. G. Cannon.
Acute phase response in exercise III: neutrophil and IL-1
accumulation in skeletal muscle.
Am. J. Physiol.
265 (Regulatory Integrative Comp. Physiol. 34):
R166-R172,
1993.
17.
Fridén, J.,
and
R. L. Lieber.
Structural and mechanical basis of exercise-induced muscle injury.
Med. Sci. Sports Exerc.
24:
521-530,
1992[Medline].
18.
Hellsten, Y.,
U. Frandsen,
N. Orthenblad,
B. Sjodin,
and
E. A. Richter.
Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation.
J. Physiol. (Lond.)
498:
239-248,
1997[Medline].
19.
Higaki, Y.,
T. Kagawa,
J. Fujitani,
A. Kiyonaga,
M. Shindo,
A. Taniguchi,
Y. Nakai,
K. Tokuyama,
M. Suzuki,
and
H. Tanaka.
Effects of a single bout of exercise on glucose effectiveness.
J. Appl. Physiol.
80:
754-759,
1996
20.
Hortobagyi, T.,
and
T. Denahan.
Variability in creatine kinase: methodological, exercise, and clinically related factors.
Int. J. Sports Med.
10:
69-80,
1989[Medline].
21.
Kuipers, H.
Exercise-induced muscle damage.
Int. J. Sports Med.
15:
132-135,
1994[Medline].
22.
Lecomte, J. M.,
V. J. Lacroix,
and
D. L. Montgomery.
A randomized controlled trial of the effect of naproxen on delayed onset muscle soreness and muscle strength.
Clin. J. Sport Med.
8:
82-87,
1998[Medline].
23.
MacIntyre, D. L.,
W. D. Reid,
D. M. Lyster,
I. J. Szasz,
and
D. C. McKenzie.
Presence of WBC, decrease strength, and delayed soreness in muscle after eccentric exercise.
J. Appl. Physiol.
80:
1006-1013,
1996
24.
MacIntyre, D. L.,
W. D. Reid,
and
D. C. McKenzie.
Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications.
Sports Med.
20:
24-40,
1995[Medline].
25.
Mair, J.,
A. Koller,
E. Artner-Dworzak,
C. Haid,
K. Wicke,
W. Judmaier,
and
B. Puschendorf.
Effects of exercise on plasma myosin heavy chain fragments and MRI of skeletal muscle.
J. Appl. Physiol.
72:
656-663,
1992
26.
Marceau, F.,
S. Brochu,
I. Pelletier,
G. Drapeau,
A. Adam,
and
M. Lebel.
Inflammatory peptides at the beginning of hemodialysis in asymptomatic patients treated or not with angiotensin I-converting inhibitors.
Nephron
71:
474-476,
1995[Medline].
27.
Marceau, F.,
J. F. Hess,
and
D. R. Bachvarov.
The B1 receptors for kinins.
Pharmacol. Rev.
50:
357-386,
1998
28.
Nosaka, K.,
and
P. M. Clarkson.
Relationship between post-exercise plasma creatine kinase elevation and muscle mass involved in the exercise.
Int. J. Sports Med.
13:
471-475,
1992[Medline].
29.
Nosaka, K.,
and
P. M. Clarkson.
Changes in indicators of inflammation after eccentric exercise of the elbow flexors.
Med. Sci. Sports Exerc.
28:
953-961,
1996[Medline].
30.
Nussberger, J.,
M. Cugno,
C. Amstutz,
M. Cicardi,
A. Pellacani,
and
A. Agostoni.
Plasma bradykinin in angio-oedema.
Lancet
351:
1693-1697,
1998[Medline].
31.
Pan, H. L.,
C. L. Stebbins,
and
J. C. Longhurst.
Bradykinin contributes to the exercise pressor reflex: mechanism of action.
J. Appl. Physiol.
75:
2061-2068,
1993
32.
Pellacani, A.,
H. R. Brunner,
and
J. Nussberger.
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Clin. Sci. (Colch.)
87:
567-574,
1994[Medline].
33.
Pyne, D. B.
Exercise-induced muscle damage and inflammation: a review.
Aust. J. Sci. Med. Sport
26:
49-58,
1994[Medline].
34.
Raymond, P.,
G. Drapeau,
R. Raut,
R. Audet,
F. Marceau,
H. Ong,
and
A. Adam.
Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
J. Immunol. Methods
180:
247-257,
1995[Medline].
35.
Rett, K.,
M. Wicklmayr,
E. Fink,
E. Maerker,
G. Dietze,
and
H. Mehnert.
Local generation of kinins in working skeletal muscle tissue in man.
Biol. Chem. Hoppe Seyler
370:
445-449,
1989[Medline].
36.
Saxton, J. M.,
A. E. Donnelly,
and
H. P. Roper.
Indices of free-radical-mediated damage following maximum voluntary eccentric and concentric muscular work.
Eur. J. Appl. Physiol.
68:
189-193,
1994.
37.
Smith, L. L.
Acute inflammation: the underlying mechanism in delayed onset muscle soreness.
Med. Sci. Sports Exerc.
23:
542-551,
1991[Medline].
38.
Stebbins, C. L.,
O. A. Carretero,
T. Mindroiu,
and
J. C. Longhurst.
Bradykinin release from contracting skeletal muscle of the cat.
J. Appl. Physiol.
69:
1225-1230,
1990
39.
Virtanen, P.,
J. T. Viitasalo,
J. Vuori,
K. Vaananen,
and
T. E. Takala.
Effect of concentric exercise on serum muscle and collagen markers.
J. Appl. Physiol.
75:
1272-1277,
1993
This article has been cited by other articles:
![]() |
R. M. Crameri, P. Aagaard, K. Qvortrup, H. Langberg, J. Olesen, and M. Kjaer Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction J. Physiol., August 15, 2007; 583(1): 365 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taguchi, J. Sato, and K. Mizumura Augmented Mechanical Response of Muscle Thin-Fiber Sensory Receptors Recorded from Rat Muscle-Nerve Preparations In Vitro After Eccentric Contraction J Neurophysiol, October 1, 2005; 94(4): 2822 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Kritchevsky, B. J. Nicklas, M. Visser, E. M. Simonsick, A. B. Newman, T. B. Harris, E. M. Lange, B. W. Penninx, B. H. Goodpaster, S. Satterfield, et al. Angiotensin-Converting Enzyme Insertion/Deletion Genotype, Exercise, and Physical Decline JAMA, August 10, 2005; 294(6): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Perez, V. Velarde, C. Acuna-Castillo, C. Gomez, S. Nishimura, V. Sabaj, R. Walter, and F. Sierra Increased Kinin Levels and Decreased Responsiveness to Kinins During Aging J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taguchi, T. Matsuda, R. Tamura, J. Sato, and K. Mizumura Muscular mechanical hyperalgesia revealed by behavioural pain test and c-Fos expression in the spinal dorsal horn after eccentric contraction in rats J. Physiol., April 1, 2005; 564(1): 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boix, C. Roe, L. Rosenborg, and S. Knardahl Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain J Appl Physiol, February 1, 2005; 98(2): 534 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Dumke, J. Kim, E. B. Arias, and G. D. Cartee Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions J Appl Physiol, February 1, 2002; 92(2): 657 - 664. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |